Management and interpretation of novel toxicities of molecular targeted therapies: renal toxicities

Eur J Cancer. 2009 Sep:45 Suppl 1:309-17. doi: 10.1016/S0959-8049(09)70045-0.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antineoplastic Agents / adverse effects*
  • Contraindications
  • Enzyme Inhibitors / adverse effects
  • ErbB Receptors / antagonists & inhibitors*
  • Humans
  • Kidney Diseases / chemically induced*
  • Neoplasms / drug therapy*
  • Renal Dialysis
  • Renal Insufficiency, Chronic / complications
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Vascular Endothelial Growth Factor A
  • ErbB Receptors